Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 (2G7F5) (MALS verified)

Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 (2G7F5) (MALS verified)

• Background: It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
• Description: Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Spike protein.
• CAS Number: 9007-83-4
• Host: Hybridoma
• Origin Species: Mouse
• Target: Spike RBD
• Conjugation: Unconjugated
• Tag: Mouse IgG1 | Mouse Kappa
• Stability: -20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution._x000D_For long term storage, the product should be stored at lyophilized state at -20°C or lower._x000D_Please avoid repeated freeze-thaw cycles.
• Purity: 95%
• Bioactivity: Immobilized SARS-CoV-2 (COVID-19) S protein RBD (Cat. No. SPD-C52H3), Alpha (Cat. No. SPD-C52Hn), Beta (Cat. No. SPD-C52Hp), Gamma (Cat. No. SPD-C52Hr), Delta (Cat. No. SPD-C52Hh), B.1.1.529/Omicron (Cat. No. SPD-C522e), BA.2/Omicron (Cat. No. SPD-C522g), BA.2.12.1/Omicron (Cat. No. SPD-C522q), BA.4&BA.5/Omicron (Cat. No. SPD-C522r), BA.3/Omicron (Cat. No. SPD-C522i) and BA.2.75/Omicron (Cat. No. SPD-C522t) at 2μg/mL (100μL/well) can bind Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 (2G7F5) (Cat. No. SPD-Y68) (QC tested).
• Format: Powder
• Buffer: PBS, pH7.4
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C